A woman with multiple sclerosis (MS) says she has been left with debilitating symptoms after the NHS switched her to a cheaper drug.
Julie Cowdrill is among scores of MS patients who say they have suffered a regression in their condition after being switched from a drug called Tysabri to one called Tyruko, with complaints that a “cost-cutting exercise” is coming at the expense of their health.
